Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
According to TipRanks, Hendrix is a 4-star analyst with an average return of 5.1% and a 54.15% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Humana, and HCA Healthcare.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for PACS Group Inc with a $42.60 average price target, representing a 3.45% upside. In a report released on January 5, Truist Financial also maintained a Buy rating on the stock with a $40.00 price target.
Based on PACS Group Inc’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.34 billion and a net profit of $52.41 million. In comparison, last year the company earned a revenue of $1.03 billion and had a net profit of $15.62 million
Based on the recent corporate insider activity of 16 insiders, corporate insider sentiment is neutral on the stock. Most recently, in November 2025, Evelyn Dilsaver, a Director at PACS bought 16,724.00 shares for a total of $499,880.36.
